Melanoma diagnosis poses tremendous challenges in dermatopathology; recent studies show discordance rates in pathology as high as one in seven[1], and the severe consequences of missing a melanoma diagnosis has increased the number of biopsies taken and lowered the threshold for diagnosis of early melanoma[2]. This leads to unknown but likely significant societal costs and morbidity from associated unnecessary treatments.

© 2011 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription